Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Andrew

Showing results (781-790 of 820) with videos related to

Pageof 82
Sort By:
JCO Global Oncology|December 15, 2025
Pediatric ALL Treatment Modifications in Low- and Middle-Income Countries: A Systematic ReviewCaitlyn Duffy, Savannah Allen, Thomas B Alexander, et al.
Nature|October 5, 2012
Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growthSergei I Grivennikov, Kepeng Wang, Daniel Mucida, et al.
Science (New York, N.Y.)|November 23, 2013
Commensal bacteria control cancer response to therapy by modulating the tumor microenvironmentNoriho Iida, Amiran Dzutsev, C Andrew Stewart, et al.
Future Medicinal Chemistry|October 23, 2013
Selection and optimization of hits from a high-throughput phenotypic screen against Trypanosoma cruziMartine Keenan, Paul W Alexander, Jason H Chaplin, et al.
Cancer Research|May 21, 2015
NOS Inhibition Modulates Immune Polarization and Improves Radiation-Induced Tumor Growth DelayLisa A Ridnour, Robert Y S Cheng, Jonathan M Weiss, et al.
Journal of the American Chemical Society|July 1, 2024
On Demand Bioorthogonal Switching of an Antibody-Conjugated SPECT Probe to a Cytotoxic Payload: from Imaging to TherapyPragya Adhikari, Guangmin Li, MaryAnn Go, et al.
American Journal of Obstetrics and Gynecology|November 27, 2013
Amniotic fluid infection, inflammation, and colonization in preterm labor with intact membranesC Andrew Combs, Michael Gravett, Thomas J Garite, et al.
European Journal of Medicinal Chemistry|October 2, 2020
Re-evaluating pretomanid analogues for Chagas disease: Hit-to-lead studies reveal both in vitro and in vivo trypanocidal efficacyAndrew M Thompson, Patrick D O'Connor, Andrew J Marshall, et al.
Molecular Cancer Research : MCR|June 6, 2019
T-Cell Deletion of MyD88 Connects IL17 and IκBζ to RAS OncogenesisChristophe Cataisson, Rosalba Salcedo, Aleksandra M Michalowski, et al.
Molecular Cancer Therapeutics|February 4, 2021
Anti-LYPD1/CD3 T-Cell-Dependent Bispecific Antibody for the Treatment of Ovarian CancerAmy A Lo, Jennifer Johnston, Ji Li, et al.
Pageof 82

Showing results (781-790 of 820) with videos related to

Sort By:
Pageof 82
JCO Global Oncology|December 15, 2025
Pediatric ALL Treatment Modifications in Low- and Middle-Income Countries: A Systematic ReviewCaitlyn Duffy, Savannah Allen, Thomas B Alexander, et al.
Nature|October 5, 2012
Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growthSergei I Grivennikov, Kepeng Wang, Daniel Mucida, et al.
Science (New York, N.Y.)|November 23, 2013
Commensal bacteria control cancer response to therapy by modulating the tumor microenvironmentNoriho Iida, Amiran Dzutsev, C Andrew Stewart, et al.
Future Medicinal Chemistry|October 23, 2013
Selection and optimization of hits from a high-throughput phenotypic screen against Trypanosoma cruziMartine Keenan, Paul W Alexander, Jason H Chaplin, et al.
Cancer Research|May 21, 2015
NOS Inhibition Modulates Immune Polarization and Improves Radiation-Induced Tumor Growth DelayLisa A Ridnour, Robert Y S Cheng, Jonathan M Weiss, et al.
Journal of the American Chemical Society|July 1, 2024
On Demand Bioorthogonal Switching of an Antibody-Conjugated SPECT Probe to a Cytotoxic Payload: from Imaging to TherapyPragya Adhikari, Guangmin Li, MaryAnn Go, et al.
American Journal of Obstetrics and Gynecology|November 27, 2013
Amniotic fluid infection, inflammation, and colonization in preterm labor with intact membranesC Andrew Combs, Michael Gravett, Thomas J Garite, et al.
European Journal of Medicinal Chemistry|October 2, 2020
Re-evaluating pretomanid analogues for Chagas disease: Hit-to-lead studies reveal both in vitro and in vivo trypanocidal efficacyAndrew M Thompson, Patrick D O'Connor, Andrew J Marshall, et al.
Molecular Cancer Research : MCR|June 6, 2019
T-Cell Deletion of MyD88 Connects IL17 and IκBζ to RAS OncogenesisChristophe Cataisson, Rosalba Salcedo, Aleksandra M Michalowski, et al.
Molecular Cancer Therapeutics|February 4, 2021
Anti-LYPD1/CD3 T-Cell-Dependent Bispecific Antibody for the Treatment of Ovarian CancerAmy A Lo, Jennifer Johnston, Ji Li, et al.
Pageof 82